Dixon Quantitative Chemical Shift Imaging Is a Sensitive Tool for the Evaluation of Bone Marrow Responses to Individualized Doses of Enzyme Supplementation Therapy in Type 1 Gaucher Disease
- 1 November 2001
- journal article
- research article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 27 (6) , 1005-1012
- https://doi.org/10.1006/bcmd.2001.0474
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Uniform Fat Suppression in Hands and Feet through the Use of Two-Point Dixon Chemical Shift MR ImagingRadiology, 1999
- Effect of Low-dose Enzyme Replacement Therapy on Bones in Gaucher Disease Patients with Severe Skeletal InvolvementBlood Cells, Molecules, and Diseases, 1996
- Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: normal variations with age and sex.American Journal of Roentgenology, 1996
- Analysis of the lipids of normal and Gaucher bone marrowJournal of Laboratory and Clinical Medicine, 1996
- Individualised low-dose alglucerase therapy for type 1 Gaucher's diseaseThe Lancet, 1995
- A Less Costly Regimen of Alglucerase to Treat Gaucher's DiseaseNew England Journal of Medicine, 1992
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Skeletal Complications of Gaucher DiseaseMedicine, 1985
- Bone marrow imaging: magnetic resonance studies related to age and sex.Radiology, 1985